You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 5, February 6, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Public Health, Other
 •Bacterial Infections
 •Infectious Diseases, Other
 •Alert me on articles by topic

Determining Whether Methicillin-Resistant Staphylococcus aureus Is Associated With Health Care

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their study of methicillin-resistant Staphylococcus aureus (MRSA), Dr Klevens and colleagues1 concluded that the majority of invasive infections have onset in the community. They also implied that the majority of community-onset invasive MRSA disease occurred in association with exposure to the health care environment.

An important question is how to define health care environment exposure. For example, 1 component of the definition for health care–associated MRSA used in the study by Klevens et al was documentation of a previous infection or colonization with MRSA. Prior to the onset of epidemic community-based MRSA disease, this criterion worked well to define health care risk because MRSA isolates were largely confined to the health care environment.2 Now, however, novel MRSA isolates (such as the widely disseminated USA300 clone, with its molecular characteristics that markedly distinguish it from the well-known health care–based MRSA strains) circulate in the community and infect . . . [Full Text of this Article]

Michael Z. David, MS, MD
mdavid@medicine.bsd.uchicago.edu
University of Chicago
Chicago, Illinois

Jane D. Siegel, MD
University of Texas Southwestern Medical Center
Dallas

Henry F. Chambers, MD
University of California, San Francisco

Robert S. Daum, MD, CM
University of Chicago


RELATED LETTER

Determining Whether Methicillin-Resistant Staphylococcus aureus Is Associated With Health Care—Reply
R. Monina Klevens, Melissa A. Morrison, and Scott K. Fridkin
JAMA. 2008;299(5):519-520.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
R. Monina Klevens, Melissa A. Morrison, Joelle Nadle, Susan Petit, Ken Gershman, Susan Ray, Lee H. Harrison, Ruth Lynfield, Ghinwa Dumyati, John M. Townes, Allen S. Craig, Elizabeth R. Zell, Gregory E. Fosheim, Linda K. McDougal, Roberta B. Carey, Scott K. Fridkin, and for the Active Bacterial Core surveillance (ABCs) MRSA Investigators
JAMA. 2007;298(15):1763-1771.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.